聯(lián)系電話
參考價(jià): | 面議 |
- ICA1023-0005MG 產(chǎn)品型號(hào)
- 品牌
- 生產(chǎn)商 廠商性質(zhì)
- 上海市 所在地
訪問(wèn)次數(shù):361更新時(shí)間:2023-03-15 09:24:41
- 聯(lián)系人:
- 曹女士
- 電話:
- 400-6111-883
- 手機(jī):
- 售后:
- 4006-111-883
- 傳真:
- 86-21-34615995
- 地址:
- 上海市浦東新區(qū)天雄路166弄1號(hào)3樓
- 網(wǎng)址:
- www.yeasen.com
掃一掃訪問(wèn)手機(jī)商鋪
ICA1023-D609,POTASSIUM SALT
D609,POTASSIUM SALT,~98%
【英文同義名】:Tricyclodecan-9-yl-xanthogenate, K
訂購(gòu)信息:(*,常備現(xiàn)貨)
品 牌 | 產(chǎn)品名稱 | 產(chǎn)品貨號(hào) | 規(guī) 格 | 目錄價(jià)(元) |
Gene Operation | D609,POTASSIUM SALT | ICA1023-0005MG | 5MG | ¥1,269.00 |
ICA1023-0025MG | 25MG | ¥4,899.00 |
產(chǎn)品描述
D609是磷脂酰膽堿特異性PLC(PC-PLC)的選擇性抑制劑,IC50為94μM [1]。D609已被用來(lái)建立PC-PLC與鞘磷脂的功能耦合,以及建立磷脂酰膽堿水解和RAF-1蛋白激酶的活化的耦合。在膜制劑(IC50=100微克/毫升)和細(xì)胞中,D609還能減弱鞘磷脂合酶的活性[2]。像其他黃原酸酯一樣,D609具有抗氧化,抗病毒和抗腫瘤活性[3]。此外,它還具有抗炎作用,在巨噬細(xì)胞中抑制脂多糖誘導(dǎo)的一氧化氮合成酶的活性(IC50=20微克/毫升),在內(nèi)皮細(xì)胞中抑制通過(guò)IL-1β的血管細(xì)胞黏附分子1的表達(dá)[4,5]。
靶點(diǎn)
靶點(diǎn) | PC-PLC |
IC50(半數(shù)有效濃度) | 94 μM [1] |
化學(xué)特性
Cas No.: 83373-60-8 | 分子量: 266.46 |
分子式: C11H15OS2K | 純度: ~98% |
同義名: Tricyclodecan-9-yl-xanthogenate, K | |
化學(xué)名: O-?(octahydro-?4,?7-?methano-?1H-?inden-?5-?yl) ester,? carbonodithioic acid,? monopotassium salt | |
外觀: 固體 | |
溶解: 溶于水 (up to 25 mg/mL) | |
保存:3年 -20℃粉狀 |
儲(chǔ)存液配制
儲(chǔ)存液 (1 ml 水體系) | 1 mM | 5 mM | 10 mM | 25 mM | 50 mM |
質(zhì)量(mg) | 0.2665 | 1.3323 | 2.6646 | 6.6615 | 13.3230 |
結(jié)構(gòu)式
使用濃度(僅作參考)
D609,POTASSIUM SALT的具體使用濃度請(qǐng)參考相關(guān)文獻(xiàn),并根據(jù)自身實(shí)驗(yàn)條件(如實(shí)驗(yàn)?zāi)康?,?xì)胞種類,培養(yǎng)特性等)進(jìn)行摸索和優(yōu)化。
參考文獻(xiàn)
[1] Amtmann E. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp Clin Res. 22(6):287-94(1996).
[2] Luberto C, Hannun YA. Sphingomyelin synthase,a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem. 273(23):14550- 9(1998).
[3] Adibhatla RM, et al. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature. Neurochem Res. 37(4):671-9(2012).
[4] Tschaikowsky K, et al. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609). Br J Pharmacol. 113(3):664-8(1994).
[5] Cobb RR, et al. D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells. Mol Pharmacol. 49(6):998-1004(1996).